COMPUGROUP MEDICAL: Doctolib makes an acquisition in Italy, and unveils an aggressive growth plan in the country | NEUTRAL | EUR84(+20%)
COMPUGROUP MEDICAL - NEUTRAL | EUR84(+20%)Doctolib makes an acquisition in Italy, and unveils an aggressive growth plan in the country
First steps in Italy - an acquisition and planned EUR250m investment
Opportunities in Italy are arising – backed by governmental funding
CompuGroup’s position in Italy is mainly linked to pharmacies
Doctolib and peers are a long-term risk for CompuGroup in Europe
Market watch: Doctolib’s Practice Management Systems in France – 1.0% market share in 6 months!
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.